Metformina Aurobindo

Metformin Hydrochloride, the active ingredient in Metformina Aurobindo, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.

GNH USA supplies Metformina Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Aurobindo is a biguanide indicated for disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): reduces the risk of progression to type 2 diabetes. - Polycystic ovary syndrome (off‑label): helps improve insulin sensitivity and may restore ovulatory cycles.

Metformina Aurobindo may cause a range of adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: watery stools, often transient. - Metallic taste: altered taste perception. - Flatulence: increased intestinal gas. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes. - Vitamin B12 deficiency: may develop with long‑term therapy. - Hypoglycemia: usually when combined with other glucose‑lowering agents.

Patients should be monitored for conditions that increase the risk of adverse events. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: evaluate liver enzymes, especially in patients with existing liver disease. - Lactic acidosis risk: avoid in patients with severe heart, respiratory, or circulatory failure. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Drug interactions: review concomitant medications that may affect metformin clearance. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Metformina Aurobindo can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Alcohol: may precipitate lactic acidosis. - Iodinated contrast agents: can cause acute renal impairment, increasing metformin accumulation. - Cimetidine: may raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemic symptoms. - Diuretics (especially thiazides): can affect renal clearance. - ACE inhibitors or ARBs: may alter renal function. - NSAIDs: increase risk of renal dysfunction. - Calcium channel blockers: may modestly raise metformin levels.